Stories

Prime Therapeutics lands No. 3 spot on Minneapolis/St. Paul Business Journal’s 2020 Top 100 Private Companies List

Prime ranked third-largest in state by revenue

September 4, 2020
For a third consecutive year, The Minneapolis/St. Paul Business Journal placed Prime at No. 3 on its 2020 Top 100 Private Companies List. Once again, Prime shares the top three with Cargill and CHS.

The annual list ranks companies by revenue. To qualify for the ranking, a company must have headquarters in Minnesota, be a for-profit operation and not issue stock to the public.

The full Top 100 Private Companies List is available now online and will publish in the Minneapolis/St. Paul Business Journal’s annual Book of Lists later this year.

About Prime Therapeutics

Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime provides total drug management solutions for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and offers clinical services for people with complex medical conditions. Prime serves more than 33 million people. It is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans.

Related news

Stories

May 25, 2022

Three Minutes with Kelly Pokuta

Dr. Kelly Pokuta is vice president, trade relations & strategy and chief trade…

Read More

Stories

May 23, 2022

Biosimilar use alone won’t cut drug costs

We see it time after time. High-potential innovation that just doesn’t seem to…

Read More

Stories

May 13, 2022

Prime expert showcases medical specialty drug management solutions

Prime Therapeutics’ (Prime) Chris Ford, assistant vice president, strategy and innovation, was a…

Read More
View all news